查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1609075

次要大麻素市场：按产品、按应用分类 - 全球预测 2025-2030

Minor Cannabinoids Market by Products (Cannabichromene, Cannabigerol, Cannabigerolic Acid), Application (Cancer, Inflammation, Neurological Disorders) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年，次要大麻素市场价值为176.3亿美元，预计到2024年将达到187.9亿美元，复合年增长率为7.95%，到2030年将达到301.3亿美元。

在快速增长的次要大麻素领域，大麻中发现的非精神活性和不太明显的化合物，如 CBG、CBN、CBC 和 THCV，定义了市场范围。这些大麻素因其潜在的治疗作用而受到关注，增加了对药品、食品和保健产品的需求。应用范围从增强睡眠、调节食慾、缓解疼痛到潜在的发炎和神经保护特性，最终用途包括药物配方、偏好、化妆品和宠物产品。消费者对自然保健疗法的认识不断提高、有利的监管变化以及大麻种植和萃取技术的进步对市场成长产生了重大影响。市场开拓机会比比皆是，包括开发有针对性的大麻素产品、临床研究合作以及扩大新兴和成熟合法市场的产品线。然而，市场面临监管模糊、提取成本高以及长期影响临床资料有限等挑战，可能会阻碍快速商业化。为了利用新的商机，公司应该投资娱乐效果的研究。针对消费者行为和偏好的资料主导策略可以指南产品创新。此外，整合区块链以提高供应链透明度和永续性可以提供竞争优势。次要大麻素市场的性质是动态的，科学合作和不断发展的立法朝着整体健康的角度增加了创新潜力。继续倡导有利的法律规范以及产品品质和安全的标准化对于永续成长至关重要。创新的重点是优化萃取方法，透过精确的剂型来最大限度地发挥功效，以及开发针对特定健康结果的多种大麻素混合物。儘管面临挑战，但市场格局有望满足不断变化的消费者需求和技术进步的业务成长。

主要市场统计
基准年[2023] 176.3亿美元
预测年份 [2024] 187.9亿美元
预测年份 [2030] 301.3亿美元
复合年增长率（%） 7.95%

市场动态：揭示快速发展的小型大麻素市场的关键市场洞察

供需的动态交互作用正在改变小规模大麻素市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 次要大麻素的医疗作用
    • 大麻素合法化的进展
    • 新的次要大麻素食品和饮料产品简介
  • 市场限制因素
    • 次要大麻素高成本
  • 市场机会
    • 持续研究和开发次要大麻素
    • 资金筹措和投资以实现更好的商业化
  • 市场挑战
    • 关于次要大麻素的严格规定

波特的五力：驾驭小型大麻素市场的策略工具

波特的五力框架是了解小大麻素市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解对次要大麻素市场的外部影响

外部宏观环境因素在塑造次要大麻素市场的表现动态方面发挥关键作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解次要大麻素市场的竞争格局

对次要大麻素市场的详细市场占有率分析可以对供应商的业绩进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 在次要大麻素市场的定位矩阵供应商绩效评估

FPNV 定位矩阵是评估次要大麻素市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议绘製小大麻素市场的成功之路

小大麻素市场的策略分析对于旨在加强其在全球市场的影响力的公司至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点关注可望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 次要大麻素的医疗益处
      • 大麻合法化取得进展
      • 新的次要大麻素食品和饮料产品简介
    • 抑制因素
      • 次要大麻素的高成本
    • 机会
      • 持续研究和开发次要大麻素
      • 为更好的产品商业化提供资金和投资
    • 任务
      • 关于次要大麻素的严格规定
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章 次要大麻素市场：副产品

  • 大麻色烯
  • 大麻醇
  • 大麻二酚酸
  • 大麻酚
  • 四氢大麻二酚

第七章 小型大麻素市场：依应用分类

  • 癌症
  • 发炎
  • 神经系统疾病
  • 疼痛管理

第八章美洲的小型大麻素市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太次要大麻素市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章 欧洲、中东和非洲的小型大麻素市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争场景分析
  • 战略分析和建议

公司名单

  • Fresh Bros Hemp Company
  • GenCanna
  • Global Cannabinoids
  • Laurelcrest
  • Mile High labs International
  • Pacific Roots, LLC
  • Rhizo Sciences
  • Sanobiotec
  • Zero Point Extraction, LLC
Product Code: MRR-3A2E844FF091

The Minor Cannabinoids Market was valued at USD 17.63 billion in 2023, expected to reach USD 18.79 billion in 2024, and is projected to grow at a CAGR of 7.95%, to USD 30.13 billion by 2030.

In the burgeoning field of minor cannabinoids, the market scope is defined by non-psychoactive and less prominent compounds found in cannabis, such as CBG, CBN, CBC, and THCV. These cannabinoids are gaining attention due to their potential therapeutic benefits, increasing their necessity in pharmaceuticals, nutraceuticals, and wellness products. Applications extend from sleep enhancement, appetite regulation, and pain relief to potential anti-inflammatory and neuroprotective effects, with end-use spanning medicinal formulations, edibles, cosmetics, and pet products. Market growth is significantly influenced by increasing consumer awareness of natural health remedies, favorable regulatory shifts, and advancements in cannabis cultivation and extraction technologies. Opportunities abound in the development of targeted cannabinoid products, partnerships aimed at clinical research, and expanding product lines in both emerging and established legal markets. However, the market faces challenges such as regulatory ambiguity, high extraction costs, and limited clinical data on long-term effects, which could hamper rapid commercialization. To capitalize on emerging opportunities, companies should invest in research focused on the entourage effect, which examines how minor cannabinoids interact with major ones for enhanced benefits. Data-driven strategies targeting consumer behavior and preferences could guide product innovation. Moreover, integrating blockchain for supply chain transparency and sustainability could offer competitive advantages. The nature of the minor cannabinoids market is dynamic, with high innovation potential driven by scientific collaborations and evolving legislations geared towards holistic health perspectives. Continued advocacy for favorable regulatory frameworks and the standardization of product quality and safety will be crucial for sustained growth. Innovation should center around optimizing extraction methods, maximizing efficacy through precise dosage forms, and developing multi-cannabinoid blends tailored to specific health outcomes. The market landscape promises growth for businesses attuned to evolving consumer needs and technological advancements, despite the presence of challenges.

KEY MARKET STATISTICS
Base Year [2023] USD 17.63 billion
Estimated Year [2024] USD 18.79 billion
Forecast Year [2030] USD 30.13 billion
CAGR (%) 7.95%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Minor Cannabinoids Market

The Minor Cannabinoids Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Medical benefits of minor cannabinoids
    • Increasing legalization of cannabinoids
    • Introduction of new minor-cannabinoid food & beverage products
  • Market Restraints
    • High cost of minor cannabinoids
  • Market Opportunities
    • Ongoing R&D of minor cannabinoids
    • Funding and investments for better product commercialization
  • Market Challenges
    • Strict regulations regarding minor cannabinoids

Porter's Five Forces: A Strategic Tool for Navigating the Minor Cannabinoids Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Minor Cannabinoids Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Minor Cannabinoids Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Minor Cannabinoids Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Minor Cannabinoids Market

A detailed market share analysis in the Minor Cannabinoids Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Minor Cannabinoids Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Minor Cannabinoids Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Minor Cannabinoids Market

A strategic analysis of the Minor Cannabinoids Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Minor Cannabinoids Market, highlighting leading vendors and their innovative profiles. These include Fresh Bros Hemp Company, GenCanna, Global Cannabinoids, Laurelcrest, Mile High labs International, Pacific Roots, LLC, Rhizo Sciences, Sanobiotec, and Zero Point Extraction, LLC.

Market Segmentation & Coverage

This research report categorizes the Minor Cannabinoids Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Products, market is studied across Cannabichromene, Cannabigerol, Cannabigerolic Acid, Cannabinol, and Tetrahydrocannabivarin.
  • Based on Application, market is studied across Cancer, Inflammation, Neurological Disorders, and Pain Management.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Medical benefits of minor cannabinoids
      • 5.1.1.2. Increasing legalization of cannabinoids
      • 5.1.1.3. Introduction of new minor-cannabinoid food & beverage products
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of minor cannabinoids
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing R&D of minor cannabinoids
      • 5.1.3.2. Funding and investments for better product commercialization
    • 5.1.4. Challenges
      • 5.1.4.1. Strict regulations regarding minor cannabinoids
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Minor Cannabinoids Market, by Products

  • 6.1. Introduction
  • 6.2. Cannabichromene
  • 6.3. Cannabigerol
  • 6.4. Cannabigerolic Acid
  • 6.5. Cannabinol
  • 6.6. Tetrahydrocannabivarin

7. Minor Cannabinoids Market, by Application

  • 7.1. Introduction
  • 7.2. Cancer
  • 7.3. Inflammation
  • 7.4. Neurological Disorders
  • 7.5. Pain Management

8. Americas Minor Cannabinoids Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Minor Cannabinoids Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Minor Cannabinoids Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Fresh Bros Hemp Company
  • 2. GenCanna
  • 3. Global Cannabinoids
  • 4. Laurelcrest
  • 5. Mile High labs International
  • 6. Pacific Roots, LLC
  • 7. Rhizo Sciences
  • 8. Sanobiotec
  • 9. Zero Point Extraction, LLC

LIST OF FIGURES

  • FIGURE 1. MINOR CANNABINOIDS MARKET RESEARCH PROCESS
  • FIGURE 2. MINOR CANNABINOIDS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL MINOR CANNABINOIDS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL MINOR CANNABINOIDS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL MINOR CANNABINOIDS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS MINOR CANNABINOIDS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS MINOR CANNABINOIDS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES MINOR CANNABINOIDS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES MINOR CANNABINOIDS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC MINOR CANNABINOIDS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC MINOR CANNABINOIDS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA MINOR CANNABINOIDS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA MINOR CANNABINOIDS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. MINOR CANNABINOIDS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. MINOR CANNABINOIDS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. MINOR CANNABINOIDS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL MINOR CANNABINOIDS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL MINOR CANNABINOIDS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL MINOR CANNABINOIDS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. MINOR CANNABINOIDS MARKET DYNAMICS
  • TABLE 7. GLOBAL MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL MINOR CANNABINOIDS MARKET SIZE, BY CANNABICHROMENE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL MINOR CANNABINOIDS MARKET SIZE, BY CANNABIGEROL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL MINOR CANNABINOIDS MARKET SIZE, BY CANNABIGEROLIC ACID, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL MINOR CANNABINOIDS MARKET SIZE, BY CANNABINOL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL MINOR CANNABINOIDS MARKET SIZE, BY TETRAHYDROCANNABIVARIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL MINOR CANNABINOIDS MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL MINOR CANNABINOIDS MARKET SIZE, BY INFLAMMATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL MINOR CANNABINOIDS MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL MINOR CANNABINOIDS MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS MINOR CANNABINOIDS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 21. ARGENTINA MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 23. BRAZIL MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 24. BRAZIL MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. CANADA MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 26. CANADA MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. MEXICO MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 28. MEXICO MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 29. UNITED STATES MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 30. UNITED STATES MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. UNITED STATES MINOR CANNABINOIDS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 32. ASIA-PACIFIC MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 33. ASIA-PACIFIC MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. ASIA-PACIFIC MINOR CANNABINOIDS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 35. AUSTRALIA MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 36. AUSTRALIA MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. CHINA MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 38. CHINA MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. INDIA MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 40. INDIA MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. INDONESIA MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 42. INDONESIA MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. JAPAN MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 44. JAPAN MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. MALAYSIA MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 46. MALAYSIA MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. PHILIPPINES MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 48. PHILIPPINES MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. SINGAPORE MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 50. SINGAPORE MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. SOUTH KOREA MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 52. SOUTH KOREA MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. TAIWAN MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 54. TAIWAN MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. THAILAND MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 56. THAILAND MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. VIETNAM MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 58. VIETNAM MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. EUROPE, MIDDLE EAST & AFRICA MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 60. EUROPE, MIDDLE EAST & AFRICA MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. EUROPE, MIDDLE EAST & AFRICA MINOR CANNABINOIDS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 62. DENMARK MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 63. DENMARK MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. EGYPT MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 65. EGYPT MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. FINLAND MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 67. FINLAND MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. FRANCE MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 69. FRANCE MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. GERMANY MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 71. GERMANY MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. ISRAEL MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 73. ISRAEL MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. ITALY MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 75. ITALY MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. NETHERLANDS MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 77. NETHERLANDS MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. NIGERIA MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 79. NIGERIA MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. NORWAY MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 81. NORWAY MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. POLAND MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 83. POLAND MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. QATAR MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 85. QATAR MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. RUSSIA MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 87. RUSSIA MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. SAUDI ARABIA MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 89. SAUDI ARABIA MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH AFRICA MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 91. SOUTH AFRICA MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. SPAIN MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 93. SPAIN MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. SWEDEN MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 95. SWEDEN MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. SWITZERLAND MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 97. SWITZERLAND MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. TURKEY MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 99. TURKEY MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED ARAB EMIRATES MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED ARAB EMIRATES MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. UNITED KINGDOM MINOR CANNABINOIDS MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 103. UNITED KINGDOM MINOR CANNABINOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. MINOR CANNABINOIDS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 105. MINOR CANNABINOIDS MARKET, FPNV POSITIONING MATRIX, 2023